PuraPharm Corporation Limited reported unaudited consolidated cash Flow results for the six months ended June 30, 2015. For the period, the company reported net cash flows used in operating activities of HKD 10,591,000 compared to HKD 496,000 a year ago. Purchases of items of property, plant and equipment was HKD 10,209,000 compared to HKD 1,460,000 a year ago.

Purchase of intangible assets was HKD 2,692,000 compared to HKD 932,000 a year ago.